{"bill":{"bill_id":1266631,"change_hash":"5b9de9cb3322c54977c0d134f11a1c7c","session_id":1658,"session":{"session_id":1658,"state_id":52,"year_start":2019,"year_end":2020,"prefile":0,"sine_die":1,"prior":1,"special":0,"session_tag":"Regular Session","session_title":"2019-2020 Regular Session","session_name":"116th Congress"},"url":"https:\/\/legiscan.com\/US\/bill\/SB1712\/2019","state_link":"https:\/\/www.congress.gov\/bill\/116th-congress\/senate-bill\/1712\/all-info","completed":0,"status":1,"status_date":"2019-06-04","progress":[{"date":"2019-06-04","event":1},{"date":"2019-06-04","event":9}],"state":"US","state_id":52,"bill_number":"SB1712","bill_type":"B","bill_type_id":"1","body":"S","body_id":115,"current_body":"S","current_body_id":115,"title":"DISARM Act of 2019 Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019","description":"Requires additional payment under Medicare's inpatient prospective payment system for services that involve certain antimicrobial drugs, in accordance with specified limitations. Additionally, the Government Accountability Office must report on the barriers to developing such antimicrobial drugs and must recommend ways to address such barriers.","pending_committee_id":2326,"committee":{"committee_id":2326,"chamber":"S","chamber_id":115,"name":"Finance"},"referrals":[{"date":"2019-06-04","committee_id":2326,"chamber":"S","chamber_id":115,"name":"Finance"}],"history":[{"date":"2019-06-04","action":"Read twice and referred to the Committee on Finance.","chamber":"S","chamber_id":115,"importance":1}],"sponsors":[{"people_id":9450,"person_hash":"i6e8frel","party_id":"2","state_id":52,"party":"R","role_id":2,"role":"Sen","name":"Johnny Isakson","first_name":"Johnny","middle_name":"","last_name":"Isakson","suffix":"","nickname":"","district":"SD-GA","ftm_eid":7238922,"votesmart_id":1721,"opensecrets_id":"N00002593","knowwho_pid":158812,"ballotpedia":"Johnny_Isakson","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0},{"people_id":9403,"person_hash":"dbwfjn2h","party_id":"1","state_id":52,"party":"D","role_id":2,"role":"Sen","name":"Robert Casey","first_name":"Robert","middle_name":"P.","last_name":"Casey","suffix":"Jr.","nickname":"Bob","district":"SD-PA","ftm_eid":5967054,"votesmart_id":2541,"opensecrets_id":"N00027503","knowwho_pid":240529,"ballotpedia":"Robert_Casey_(Pennsylvania)","sponsor_type_id":2,"sponsor_order":2,"committee_sponsor":0,"committee_id":0,"state_federal":0},{"people_id":11199,"person_hash":"crmbr7rg","party_id":"1","state_id":52,"party":"D","role_id":2,"role":"Sen","name":"Richard Blumenthal","first_name":"Richard","middle_name":"","last_name":"Blumenthal","suffix":"","nickname":"","district":"SD-CT","ftm_eid":6378136,"votesmart_id":1568,"opensecrets_id":"N00031685","knowwho_pid":218586,"ballotpedia":"Richard_Blumenthal","sponsor_type_id":2,"sponsor_order":3,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[{"type_id":8,"type":"Related","sast_bill_number":"HB4100","sast_bill_id":1272411}],"subjects":[{"subject_id":13304,"subject_name":"Health"},{"subject_id":13146,"subject_name":"Congressional oversight"},{"subject_id":13593,"subject_name":"Drug safety, medical device, and laboratory regulation"},{"subject_id":13200,"subject_name":"Government information and archives"},{"subject_id":22688,"subject_name":"Government studies and investigations"},{"subject_id":13706,"subject_name":"Infectious and parasitic diseases"},{"subject_id":13242,"subject_name":"Medicare"}],"texts":[{"doc_id":2037215,"date":"2019-06-12","type":"Introduced","type_id":1,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/US\/text\/SB1712\/id\/2037215","state_link":"https:\/\/www.congress.gov\/116\/bills\/s1712\/BILLS-116s1712is.pdf","text_size":373027,"text_hash":"302be9a10b00060afef5b76be87f2a9b"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}